Rafael Holdings, Inc. has entered into a merger agreement with Cyclo Therapeutics, extending the merger deadline to March 31, 2025, and holds approximately 39.5% of Cyclo's stock.
AI Assistant
RAFAEL HOLDINGS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.